JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2008, 57(2):99-102

Contribution of allergen immunotherapy using Phostal in the treatment of seasonal allergic rhinitis (two years of use)

L. Bartošíková1,*, J. Nečas1, T. Bartošík2, M. Pavlík2, J. Fráňová3
1 Univerzita Palackého v Olomouci, Lékařská fakulta, Ústav fyziologie
2 Fakultní nemocnice U sv. Anny v Brně, Anesteziologicko-resuscitační klinika
3 Fakultní nemocnice Brno, Dětská nemocnice, II. dětská klinika

Allergen immunotherapy consists in the administration of the appropriate allergen to which the patient is hypersensitive. The objective is to induce immunological tolerance of the organism. In the present study, the effect of the administration of Phostal on the occurrence of seasonal symptoms of pollinosis in a group of 35 outpatients was observed during two years. The substance was administered according to the regular dosage schedule, all year round. The results of the study have demonstrated a significant effect of the product on the decrease in the occurrence of observed objective symptoms of the disease, starting already from the first year of treatment. This is in correlation with changes in the spirometric functions, selected laboratory parameters and results of the prick tests in the treated group in comparison to the control group.

Keywords: allergen immunotherapy; pollinosis; Phostal

Received: January 24, 2008; Accepted: February 28, 2008; Published: February 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartošíková L, Nečas J, Bartošík T, Pavlík M, Fráňová J. Contribution of allergen immunotherapy using Phostal in the treatment of seasonal allergic rhinitis (two years of use). Čes. slov. farm. 2008;57(2):99-102.
Download citation

References

  1. Noon, L.: Lancet, 1911; 1, 1572-1573. Go to original source...
  2. Freeman, J.: Lancet, 1914; 1, 1178. Go to original source...
  3. Rybníček, O., Seberová, E.: Průvodce alergenovou imunoterapií. 1. vyd. Praha, ČIPA, 2004.
  4. Pereira, C., Botelho, F., Tavarez, B.: Allerg. Immunol., 2004; 36, 375-386.
  5. Schmidt-Weber, C. B., Laser, K.: Curr. Opin. Aller. Clin. Immunol., 2005; 5, 525-530. Go to original source... Go to PubMed...
  6. Akdis, C. A., Barlan, I. B., Bahceciler, N., Akdis, M.: Allergy, 2006; 61 (Suppl 81), 11-14. Go to original source... Go to PubMed...
  7. Batard, T.: Alergie, 1999; 3, 12-14. Go to original source...
  8. Bouquet, J., Jockey, H. J.: Allergy, 1998; 53 (Suppl. 44), 4-42.
  9. Bartošíková, L., Fráňa, L., Nečas, J., Fráňa, P.: Klin. Imunol. Alergol., 2000; 1, 5-10.
  10. Santilli, J., Nathan, R.: Ann. Allergy Asthma Immunol., 2001; 86, 219-225. Go to original source... Go to PubMed...
  11. Miller, C., Dreborg, S., Ferdousi, H. A. et al.: J. Allergy Clin. Immunol., 2002; 109, 251-256. Go to original source... Go to PubMed...
  12. Feliziani, V.: Allergol. Immunopathol., 1995; 23, 224-230.
  13. Gonzales, P., Florido, F.: J. Invest. Allerg. Clin Immunol., 2002; 12, 263-271.
  14. Vondra, V., Malý, M., Rybníček, O. et al.: Alergie, 2004; 1, www.tigis.cz.
  15. Park, H. S., Hahm, D. H., Kim, H. Y. et al.: Ann. Allergy. Asthma Immunol., 2001; 86, 444-448. Go to original source... Go to PubMed...
  16. Tonnel, A. B., Scherpereel, A.: Allergy, 2004; 59, 491-497. Go to original source... Go to PubMed...
  17. Hansen, I., Normann, K.: Laryngo Rhin. Otol., 2003; 82, 558-563. Go to original source... Go to PubMed...
  18. Polosa, R., Gotti M., Li, F., Mangano, G.: J. Brit. Soc. Allergy, 2003; 33, 873-881. Go to original source... Go to PubMed...
  19. Wilson, D. R., Lima, L., Torres, M., Durham, S. R.: Allergy, 2005; 1, 4-12. Go to original source... Go to PubMed...
  20. Ariano, R., Orion, A. M., Augeri, G. et al.: Allergy, 1999; 54(4), 313-319. Go to original source... Go to PubMed...
  21. Di Rienzo, V., Marcucci, F., Puccinelli, P. et al.: Clin. Exp. Allergy, 2003; 33, 206-210. Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.